CFTR and cystic fibrosis: We also verified that the proposed combination treatment has no toxicity in a CF human context, by using the human epithelial bronchial cells homozygous for F508del mutation (CuFi-1) and macrophage-like THP-1 with pharmacological inhibition of CFTR activity.